VERACYTE INC
VCYTNASDAQ🏆 #1449 by market capEarnings Nov 4 · PostUS Equity
$52.23▲ $1.93 (+3.83%)
🌙 After hours$52.44▲ 0.40%Regular close · extended-hours price shownTrack VCYT
Get earnings, price moves & breaking news on Telegram
24h▲ 3.8%
7d▲ 13.3%
14d▲ 17.7%
30d▲ 13.3%
ytd▲ 24.0%
1y▲ 47.4%
🏦Market Cap
$4.20B
Small Cap
📈Revenue Growth (YoY)
17.3%
Healthy
📊Gross Margin
71.7%
High
💵FCF Margin
29.5%
Strong
⚖️P/S Ratio
7.2x
Fair
Otter Score
80
Strong
VERACYTE INC
VCYTAnalyst Ratings
Price
$52.23
Total
22
Raised
0
Lowered
4
Avg PT
$57.43
H / L
$69 / $44
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Freedom Capital Markets | Reiterated | Buy | 2026-09-15 | — | — |
UBS | Reiterated | Buy | 2026-09-09 | $65.00 | +24.40% |
Morgan Stanley | Reiterated | Underweight | 2026-08-04 | $44.00 | −15.80% |
Piper Sandler | Reiterated | Overweight | 2026-08-04 | $54.00 | +3.40% |
Stephens & Co. | Reiterated | Overweight | 2026-08-04 | — | — |
Canaccord Genuity | Reiterated | Hold | 2026-08-03 | $50.00 | −4.30% |
Needham | Reiterated | Buy | 2026-07-31 | $69.00 | +32.10% |
Guggenheim | Reiterated | Buy | 2026-06-29 | $65.00 | +24.40% |
Goldman Sachs | Downgraded | Buy → Neutral | 2024-12-05 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2024-11-08 | — | — |
Leerink Partners | Reiterated | Outperform | 2024-10-17 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2023-01-18 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-11-03 | — | — |
Truist Securities | Reiterated | Buy | 2021-05-18 | — | — |
KeyBanc | Reiterated | Sector Weight → Equal Weight | 2020-11-10 | — | — |
BTIG | Reiterated | Buy | 2020-11-04 | — | — |
Lake Street | Reiterated | Buy | 2019-07-31 | — | — |
Janney Capital | Downgraded | Buy → Neutral | 2018-11-29 | — | — |
Janney Montgomery Scott | Downgraded | Buy → Neutral | 2018-11-29 | — | — |
Leerink Swann | Reiterated | Outperform | 2017-11-07 | — | — |
BTIG Research | Reiterated | Buy | 2015-04-06 | — | — |
PiperJaffray | Reiterated | Overweight | 2014-06-20 | — | — |
Institution
Freedom Capital Markets
Reiterated · Buy · 2026-09-15
—
—
UBS
Reiterated · Buy · 2026-09-09
$65.00
+24.40%
Morgan Stanley
Reiterated · Underweight · 2026-08-04
$44.00
−15.80%
Piper Sandler
Reiterated · Overweight · 2026-08-04
$54.00
+3.40%
Stephens & Co.
Reiterated · Overweight · 2026-08-04
—
—
Canaccord Genuity
Reiterated · Hold · 2026-08-03
$50.00
−4.30%
Needham
Reiterated · Buy · 2026-07-31
$69.00
+32.10%
Guggenheim
Reiterated · Buy · 2026-06-29
$65.00
+24.40%
Goldman Sachs
Downgraded · Buy → Neutral · 2024-12-05
—
—
Scotiabank
Reiterated · Sector Outperform · 2024-11-08
—
—
Leerink Partners
Reiterated · Outperform · 2024-10-17
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2023-01-18
—
—
SVB Leerink
Reiterated · Outperform · 2022-11-03
—
—
Truist Securities
Reiterated · Buy · 2021-05-18
—
—
KeyBanc
Reiterated · Sector Weight → Equal Weight · 2020-11-10
—
—
BTIG
Reiterated · Buy · 2020-11-04
—
—
Lake Street
Reiterated · Buy · 2019-07-31
—
—
Janney Capital
Downgraded · Buy → Neutral · 2018-11-29
—
—
Janney Montgomery Scott
Downgraded · Buy → Neutral · 2018-11-29
—
—
Leerink Swann
Reiterated · Outperform · 2017-11-07
—
—
BTIG Research
Reiterated · Buy · 2015-04-06
—
—
PiperJaffray
Reiterated · Overweight · 2014-06-20
—
—
One row per institution · price target from the firm's latest published target